文献速递乳腺癌支持与姑息治疗

乳腺癌放疗后急性冠状动脉事件预测:整合基线心血管风险、全身治疗与心脏放射剂量

Predicting acute coronary events after breast cancer radiotherapy: Integrating baseline cardiovascular risk, systemic therapy, and cardiac radiation dose in the MEDIRAD BRACE study.
PubMed 文献 · Eur J Cancer · 2025-10-25

MEDIRAD BRACE研究基于2005-2015年接受术后放疗的乳腺癌患者开发集(n=4305)和外部集(n=1503),构建预测急性冠状动脉事件(ACE)的Cox模型。含7个临床参数、全心脏Dmean、左心室V5及总冠状动脉钙化体积的模型3预测性能最佳,内部验证c-index为0.78(95%CI 0.72-0.83),可指导放疗剂量优化。

要点

  • 含7个临床参数、全心脏Dmean、左心室V5和总CAC体积的模型3预测ACE最佳。
  • 模型3内部验证c-index为0.78(95%CI 0.72-0.83)。
  • 开发集10年ACE累积发生率为4.8%,外部集为1.4%。

核心结论

  • 包含7个临床参数、全心脏Dmean、左心室V5和总冠状动脉钙化体积的模型最能预测ACE风险,可能指导放疗剂量优化策略。

研究设计与样本

  • 开发集4305例和外部集1503例接受术后放疗(2005-2015年)的乳腺癌患者,基于三维CT计划获取心脏剂量体积直方图参数。
  • 采用多因素病因特异性Cox回归模型预测ACE并考虑全因死亡风险,通过自举法进行内部验证,并在外部人群探索性评估模型性能。

主要发现

  • 开发集10年ACE累积发生率为4.8%,外部集为1.4%。
  • 模型2(含全心脏D1、左心室V6和右心室V6)未优于模型1(LR p=0.422)。
  • 模型3在模型1基础上加入总冠状动脉钙化体积,预测性能显著提升(LR p<0.001)。
  • 内部验证时各模型10年c-index均高于0.73,模型3最佳(c-index 0.78;95%CI 0.72-0.83)。

关键数值与推荐

  • 模型1包含7个临床参数、全心脏Dmean和左心室V5。
  • 模型3为模型1参数加总冠状动脉钙化体积,内部验证c-index 0.78(95%CI 0.72-0.83)。

临床怎么用

  • 可将包含临床参数、全心脏Dmean、左心室V5和总CAC体积的模型用于乳腺癌放疗后ACE风险预测,辅助放疗剂量优化决策。

局限性

  • 外部评估为探索性,外部集ACE累积发生率(1.4%)低于开发集(4.8%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to develop prediction models for acute coronary events (ACE) following breast cancer (BC) radiation therapy (RT). PATIENTS AND METHODS: The cohort included a development set (n = 4305) and an external set (n = 1503) of BC patients treated with postoperative RT (2005-2015). Cardiac dose-volume histogram (DVH) parameters were obtained from three-dimensional CT-based planning. Multivariable cause-specific Cox regression models predicted ACE, accounting for overall mortality risk. Model 1 included seven clinical parameters, whole heart (WH)-Dmean, and left ventricle (LV)-V5. Model 2 replaced WH-Dmean and LV-V5 with cardiac DVH parameters offering higher prognostic value. Model 3 was built by testing whether the better-performing model was enhanced by adding left anterior descending artery DVH parameters, coronary artery calcium (CAC) volumes, or CAC DVH parameters. The incremental value of adding a parameter (or to compare models) was assessed using the likelihood ratio (LR) test. Internal validation was done via bootstrapping. An exploratory assessment of the models' performance in an external population was performed. RESULTS: At ten years, the cumulative incidence of ACE was 4.8 % and 1.4 % in the development and external sets, respectively. Model 2, which included WH-D1, LV-V6, and right ventricle (RV)-V6, did not outperform Model 1 (LR p = 0.422). Consequently, further model improvement was pursued by expanding Model 1 rather than Model 2. The resulting Model 3 incorporated the parameters from Model 1 along with the total CAC volume, significantly enhancing predictive performance (LR p < 0.001). At 10 years post-RT, each model had c-indexes above 0.73 at internal validation, with Model 3 performing best (c-index 0.78; 95 % CI, 0.72-0.83) CONCLUSION: A model including seven clinical parameters, WH-Dmean, LV-V5, and total CAC volume best predicted ACE risk and may guide RT dose optimisation strategies.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Spoor DS, Boekel NB, Leeuwen FEV, et al. Predicting acute coronary events after breast cancer radiotherapy: Integrating baseline cardiovascular risk, systemic therapy, and cardiac radiation dose in the MEDIRAD BRACE study. Eur J Cancer. 2025. PMID: 41172565. doi:10.1016/j.ejca.2025.116055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。